← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Senti Biosciences Holdings SNTI $8.14M	39	-5	-11%	$209M
77	77 Imunon IMNN $5.95M	37	0	0%	$8.54M
78	78 DELISTED NKGen Biotech, Inc. Common Stock NKGN	37	+37	–	$92.6M
79	DBTX 79 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	36	-10	-22%	$146M
80	GRCL 80 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	34	+2	+6%	$450M
81	81 Lunai Bioworks LNAI $3.74M	32	-5	-14%	$10.2M
82	ONCS 82 DELISTED OncoSec Medical Incorporated ONCS	31	-4	-11%	$13.8M
83	83 Capricor Therapeutics CAPR $423M	30	-1	-3%	$10M
84	84 Opus Genetics IRD $337M	30	-6	-17%	$8.62M
85	85 DELISTED Scorpius Holdings, Inc. SCPX	29	+1	+4%	$16.8M
86	BLCM 86 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	28	-2	-7%	$4.48M
87	87 Genprex GNPX $1.88M	28	-4	-13%	$15.8M
88	88 TScan Therapeutics TCRX $16.2M	27	+27	–	$83.5M
89	89 DELISTED Orgenesis Inc. Common Stock ORGS	26	-7	-21%	$9M
90	KRBP 90 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	23	+8	+53%	$7.49M
91	91 BioCardia BCDA $14.2M	22	+2	+10%	$9.01M
92	92 PharmaCyte Biotech PMCB $3.84M	22	+22	–	$4.42M
93	RCOR 93 DELISTED Renovacor, Inc. RCOR	22	-3	-12%	$64.5M
94	94 Celularity CELU $43.2M	21	-12	-36%	$8.42M
95	ACHL 95 DELISTED Achilles Therapeutics ACHL	20	-9	-31%	$137M
96	96 Enlivex Ltd ENLV $4.46M	20	0	0%	$8.38M
97	FRLN 97 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	20	+4	+25%	$36.1M
98	98 Benitec Biopharma BNTC $295M	18	+2	+13%	$5.43M
99	99 Estrella Immunopharma ESLA $23.3M	16	+16	–	$28.7M
100	SCPS 100 DELISTED Scopus BioPharma Inc. Common Stock SCPS	14	-1	-7%	$1.14M